Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients - Goldschmidt, Hartmut; Sonneveld, P.; Cremer, Friedrich Walter; Holt, B. van der; Westveer, P.; Breitkreutz, Iris; Benner, Axel; Glasmacher, A.; Schmidt-Wolf, I. G. D.; Martin, H.; Hoelzer, D.; Ho, Anthony Dick; et al. (Annals of hematology, 2003)
Gesehen am 11.02.2022